• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过葡萄糖包封增强作用,CdO NPs 对多重耐药大肠杆菌的疗效。

Enhancing using glucose encapsulation, the efficacy of CdO NPs against multi-drug resistant Escherichia coli.

机构信息

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow 226026, India.

Department of Physics (Nanoscience), Integral University, Lucknow 226026, India.

出版信息

Microb Pathog. 2018 Jun;119:42-48. doi: 10.1016/j.micpath.2018.04.011. Epub 2018 Apr 7.

DOI:10.1016/j.micpath.2018.04.011
PMID:29635050
Abstract

In this study, monodispersed, highly biocompatible and substantially stable glucose encapsulated CdO nanoparticles (G-CdO NPs) of uniform sizes were synthesized using a sol-gel route. In addition, naked CdO (n-CdO) NPs without any capping or surface functionalization were synthesized using the same method. These NPs were uniformly dispersed in an aqueous solution. The synthesis of G-CdO and n-CdO NP was confirmed by UV-Vis spectroscopy, transmission electron microscopy (TEM), zeta potential, and dynamic light scattering analyses. The average size of G-CdO and n-CdO NP was found to be 17±1and 27 ± 1 nm, under TEM, respectively. X-ray diffraction analysis of G-CdO and n-CdO NPs confirmed their sizes to be 18.83 and 28.41 nm, respectively, and revealed their cubic crystal structures with no impurity. The surface functionalization of G-CdO NPs with glucose was confirmed by Nuclear Magnetic Resonance and Fourier-transform infrared spectroscopy analyses. As per our knowledge, this is the first report to investigate the potencies of G-CdO and n-CdO NPs against gram-negative and gram-positive multi-drug resistant (MDR) bacteria. The minimum inhibitory concentrations of G-CdO and n-CdO NPs were6.42 and 16.29 μg/ml, respectively, against Escherichia coli (NCIM 2571-MDR), whereas 7.5 μg/ml & 11.6 μg/ml, respectively against S. aureus (NCIM- 2079) as determined by the double dilution method. The minimum bactericidal concentration was determined at the concentration for which no growth was observed. TEM analysis of E. coli cells treated with G-CdO NPs revealed cell shrinkage and degraded cell membranes, while the cell surfaces of untreated viable cells were smooth.

摘要

在这项研究中,使用溶胶-凝胶法合成了单分散、高生物相容性和高度稳定的葡萄糖包封的 CdO 纳米粒子(G-CdO NPs)。此外,还使用相同的方法合成了没有任何封端或表面功能化的裸 CdO(n-CdO)纳米粒子。这些纳米粒子均匀分散在水溶液中。通过紫外-可见光谱、透射电子显微镜(TEM)、Zeta 电位和动态光散射分析证实了 G-CdO 和 n-CdO NP 的合成。TEM 下 G-CdO 和 n-CdO NP 的平均粒径分别为 17±1 和 27±1nm。G-CdO 和 n-CdO NPs 的 X 射线衍射分析证实其尺寸分别为 18.83nm 和 28.41nm,均为立方晶体结构,无杂质。通过核磁共振和傅里叶变换红外光谱分析证实了 G-CdO NPs 的葡萄糖表面功能化。据我们所知,这是首次研究 G-CdO 和 n-CdO NPs 对革兰氏阴性和革兰氏阳性多药耐药(MDR)细菌的潜力。通过双稀释法测定,G-CdO 和 n-CdO NPs 对大肠杆菌(NCIM 2571-MDR)的最小抑菌浓度分别为 6.42μg/ml 和 16.29μg/ml,而对金黄色葡萄球菌(NCIM-2079)的最小抑菌浓度分别为 7.5μg/ml 和 11.6μg/ml。最低杀菌浓度是在没有观察到生长的浓度下确定的。用 TEM 分析用 G-CdO NPs 处理的大肠杆菌细胞,发现细胞收缩和细胞膜降解,而未经处理的活细胞表面光滑。

相似文献

1
Enhancing using glucose encapsulation, the efficacy of CdO NPs against multi-drug resistant Escherichia coli.通过葡萄糖包封增强作用,CdO NPs 对多重耐药大肠杆菌的疗效。
Microb Pathog. 2018 Jun;119:42-48. doi: 10.1016/j.micpath.2018.04.011. Epub 2018 Apr 7.
2
Down-top nanofabrication of binary (CdO) (ZnO) nanoparticles and their antibacterial activity.二元(CdO)(ZnO)纳米颗粒的自顶向下纳米制造及其抗菌活性。
Int J Nanomedicine. 2017 Nov 20;12:8309-8323. doi: 10.2147/IJN.S150405. eCollection 2017.
3
Synthesis, characterizations and anti-bacterial activities of pure and Ag doped CdO nanoparticles by chemical precipitation method.采用化学沉淀法合成纯CdO纳米颗粒及Ag掺杂CdO纳米颗粒、表征及其抗菌活性
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt C:1751-9. doi: 10.1016/j.saa.2014.10.078. Epub 2014 Nov 4.
4
Antibacterial efficacy of silver nanoparticles against multi-drug resistant clinical isolates from post-surgical wound infections.银纳米颗粒对手术伤口感染的多重耐药临床分离株的抗菌效果。
Microb Pathog. 2017 Jun;107:327-334. doi: 10.1016/j.micpath.2017.04.013. Epub 2017 Apr 11.
5
Bio-fabricated silver nanoparticles preferentially targets Gram positive depending on cell surface charge.生物制造的银纳米颗粒优先靶向革兰氏阳性菌,这取决于细胞表面电荷。
Biomed Pharmacother. 2016 Oct;83:548-558. doi: 10.1016/j.biopha.2016.07.011. Epub 2016 Jul 21.
6
Experimental and computational assessment of mycosynthesized CdO nanoparticles towards biomedical applications.实验与计算评估真菌合成 CdO 纳米粒子在生物医学中的应用。
J Photochem Photobiol B. 2018 Mar;180:166-174. doi: 10.1016/j.jphotobiol.2018.02.009. Epub 2018 Feb 7.
7
Starch-mediated synthesis of mono- and bimetallic silver/gold nanoparticles as antimicrobial and anticancer agents.淀粉介导的单金属和双金属银/金纳米粒子的合成作为抗菌和抗癌剂。
Int J Nanomedicine. 2019 Mar 27;14:2171-2190. doi: 10.2147/IJN.S192757. eCollection 2019.
8
Microbial synthesized cadmium oxide nanoparticles induce oxidative stress and protein leakage in bacterial cells.微生物合成的氧化镉纳米颗粒会导致细菌细胞内氧化应激和蛋白质渗漏。
Microb Pathog. 2020 Jul;144:104188. doi: 10.1016/j.micpath.2020.104188. Epub 2020 Apr 6.
9
Photocatalytic and antibacterial activities of gold and silver nanoparticles synthesized using biomass of Parkia roxburghii leaf.利用帕克叶生物量合成的金和银纳米颗粒的光催化及抗菌活性
J Photochem Photobiol B. 2016 Jan;154:1-7. doi: 10.1016/j.jphotobiol.2015.11.004. Epub 2015 Nov 10.
10
Synthesis and characterization of microbial mediated cadmium oxide nanoparticles.微生物介导合成氧化镉纳米粒子及其特性研究。
Microsc Res Tech. 2020 Dec;83(12):1574-1584. doi: 10.1002/jemt.23553. Epub 2020 Aug 5.

引用本文的文献

1
Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations.纳米医学对抗抗菌药物耐药性:近期药物创新概述
Pharmaceutics. 2020 Feb 8;12(2):142. doi: 10.3390/pharmaceutics12020142.
2
Corn cob silica as an antibacterial support for silver nanoparticles: efficacy on Escherichia coli and Listeria monocytogenes.玉米芯硅作为银纳米粒子的抗菌载体:对大肠杆菌和单核细胞增生李斯特菌的功效。
Environ Monit Assess. 2018 Sep 12;190(10):583. doi: 10.1007/s10661-018-6954-2.